Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering
-
Grain Shippers Call for Immediate Action to Avoid Rail Strike
-
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
-
Jamf Announces Upcoming Conference Participation
-
FreightCar America, Inc. Reports Second Quarter 2024 Results
-
KULR Technology Group Reports Second Quarter 2024 Financial Results
-
Mercury Appoints Brad Whittington as Senior Vice President of Engineering
-
Global Ship Lease Provides Update on Refinancing Activity
-
Sanara MedTech Inc. Announces Second Quarter 2024 Results
-
AssetMark Enhances Advisor Offerings with Expanded Cash Solutions Suite
-
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Crescent Capital BDC, Inc. Reports Second Quarter 2024 Earnings Results; Declares a Third Quarter Base Dividend of $0.42 Per Share, and a Second Quarter Supplemental Dividend of $0.09 Per Share
-
Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Quanex Building Products Appoints Manish Shah and Amit Singhi to Board of Directors
-
DHT Holdings, Inc. Second Quarter 2024 Results
-
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
-
Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock
-
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
-
Rumble Cloud Partners with the Miami Dolphins and Hard Rock Stadium
-
Graf Global Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about August 16, 2024
-
Enovis to Participate in Upcoming Investor Conferences
-
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results
-
Spectral AI Announces 2024 Second Quarter Financial Results
-
Surrozen Provides Second Quarter 2024 Financial Results and Business Update
-
Bridger Aerospace Announces Second Quarter 2024 Results
-
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Sma
-
Aspira Women’s Health Reports Second Quarter 2024 Financial Results
-
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
-
Stereotaxis Reports 2024 Second Quarter Financial Results
-
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
-
Archrock, Inc. Announces Tender Offer for Outstanding Notes
-
TeraWulf Reports Second Quarter 2024 Financial Results
-
Rumble Reports Second Quarter 2024 Results
-
Cibus to Participate in Upcoming August Investor Events
-
Biora Therapeutics Announces Funding Agreement with Existing Investors
-
Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Stronghold Digital Mining Sets Second Quarter 2024 Earnings Conference Call for Wednesday, August 14 at 11:00 a.m. Eastern Time
-
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
-
Firefly Neuroscience Announces Closing of Merger Agreement and is Scheduled to Begin Trading on Nasdaq Under the Ticker Symbol ‘AIFF’ on August 13, 2024
-
Valitor to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
-
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
-
Exodus Reports Second Quarter 2024 Results
-
Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
LM Funding America, Inc. Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
-
BBSI Expands Business Operations to Pocatello, Idaho
-
Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
-
DoubleDown Interactive Reports Second Quarter 2024 Financial Results
-
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
